Investigating the comparison therapeutic effect of 5% saline versus 3% in the hospitalized patient with Acute Bronchiolitis.
Phase 3
Recruiting
- Conditions
- Acute Bronchiolitis.Acute Bronchiolitis
- Registration Number
- IRCT20181006041252N4
- Lead Sponsor
- Sabzevar University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 94
Inclusion Criteria
Children aged 1 to 24 months with moderate to severe Bronchiolitis and clinical scores >= 4
Exclusion Criteria
The presence of underlying disease (cystic fibrosis, congenital heart disease, immune deficiency)
Get antibiotics before studying
Get Cortisone Inhaled and Systemic
Recent use of bronchodilators
History of immaturity and gestational age less than 32 weeks
Chronic pulmonary disease
History of NICU admission
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determine the Modified Respiratory Assessment Score (MRAS). Timepoint: At the beginning of the study (before the intervention) and daily until discharge. Method of measurement: Using the modified respiratory assessment score.
- Secondary Outcome Measures
Name Time Method Determine the respiratory sounds (Vising). Timepoint: At the beginning of the study (before the intervention) and daily until discharge. Method of measurement: Auscultation of the lungs with Stethoscope.;Respiratory Rate. Timepoint: At the beginning of the study (before the intervention) and daily until discharge. Method of measurement: The number of chest or abdominal cramps in 15 seconds or 1 minute.;Determine the level of peripheral capillary oxygen saturation (SPO2). Timepoint: At the beginning of the study (before the intervention) and daily until discharge. Method of measurement: Pulse Oximeter or Oxygenometer.